Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

ProShares Ultra Nasdaq Biotechnology

BIBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$56.86

-0.24-0.42%

At close: -

$57.12

0.260.46%

After Hours: Feb 21, 4:57 PM EDT

News

Holdings Dividends Short Interest

Latest news for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, February 20, 2023

Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
Charles Gross

Friday, December 17, 2021

Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Nina Zdinjak

Monday, March 09, 2020

Shares of several Chinese companies are tradi...
Benzinga Newsdesk

Tuesday, August 01, 2017

3 ETFs To Watch Out For On Biotech Earnings
Benzinga

Monday, October 17, 2016

Exclusive: SunTrust Managing Director Goes Over Sarepta Therapeutics' Story
Benzinga

Thursday, October 13, 2016

Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
Benzinga

Wednesday, June 22, 2016

Biotechs Are Ripping Following IPAB Ruling
Benzinga

Tuesday, March 15, 2016

New Study Suggests Drug Prices Have Doubled Since 2011: What's It Mean For The Market?
Benzinga

Tuesday, June 23, 2015

ProShares Releases 2 New Leveraged Biotech ETFs
Benzinga

Wednesday, August 06, 2014

Why Investors Should Closely Watch Celgene
Benzinga

Thursday, April 24, 2014

UCB Sales Rise in Q1 - Analyst Blog
Benzinga

Saturday, October 05, 2013

Seven ETFs On A Roll (BIB, SOCL, TAN)
Benzinga

Friday, March 08, 2013

If Stocks Keep Soaring, Get to Know These Leveraged ETFs
Benzinga

Friday, September 21, 2012

ProShares to Split 2, Reverse Split 9 ETFs
Benzinga

Friday, July 13, 2012

Low Volume, High Returns for These ETFs (BIB, FHC, DRW)
Benzinga

Wednesday, May 02, 2012

Nine ETFs on a Roll (DRN, TQQQ, BIB, BGU)
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved